Early Psychological Intervention After Rape

NCT05489133 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2026-05-08

No results posted yet for this study

Summary

Rape is a common cause of post-traumatic stress disorder (PTSD) among women, as around 30-50% will develop PTSD in the aftermath of rape. A modified protocol based on Prolonged Exposure Therapy (mPE), has been developed, consisting of three to five once or twice weekly 60 minutes sessions, and studies indicate that if implemented early after rape, mPE may prevent the development of PTSD. The aim of the study is to conduct a multi-site (4 Sexual assault care centers in Norway) randomized control trial (RCT) in which patients are recruited early after rape, and randomized to intervention (mPE) or treatment as usual (TAU).

Conditions

  • Post Traumatic Stress Disorder
  • Rape Sexual Assault
  • Sexual Dysfunctions, Psychological
  • Pelvic Floor Myalgia
  • Pelvic Pain Syndrome
  • Depression, Anxiety
  • Sleep Disturbance
  • Activity, Motor
  • Cortisol Deficiency

Interventions

BEHAVIORAL

Modified prolonged exposure

Imaginary and in vivo expo, in addition to psychoeducation

Sponsors & Collaborators

  • Norwegian University of Science and Technology

    collaborator OTHER
  • The Research Council of Norway

    collaborator OTHER
  • Norwegian Women's Public Health Association (Norske Kvinners Sanitetsforening)

    collaborator UNKNOWN
  • National Centre for Emergency Primary Health Care, NORCE

    collaborator UNKNOWN
  • UiT The Arctic University of Norway

    collaborator OTHER
  • St. Olavs Hospital

    lead OTHER

Principal Investigators

  • Cecilie T Hagemann · St. Olavs Hospital

  • Joar Ø Halvorsen · St. Olavs Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-14
Primary Completion
2026-02-07
Completion
2027-03-15

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05489133 on ClinicalTrials.gov